Evidence map›Paper›PMID 24743136›Full record

ReviewJournal of perinatology : official journal of the California Perinatal Association2014

End-tidal carbon monoxide and hemolysis.

G F Tidmarsh, R J Wong, D K Stevenson

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of perinatology : official journal of the California Perinatal Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05475223 naunknown statusnot on this mapstarted 2022, after this paper: background citation

End Tidal Carbon Monoxide (ETCO) : A Tool to Aid Identification of Neonatal Hemolysis

TypeinterventionalSponsorCedars-Sinai Medical CenterRan2022 to 2022Enrolled350ConditionsEnd Tidal Carbon Monoxide Excretion as a Diagnostic Tool for Hemolysis in the Newborn, Neonatal Jaundice, End Tidal Carbon MonoxideArmsEnd Tidal Carbon Monoxide Value
NCT05842109 recruitingnot on this mapstarted 2023, after this paper: background citation

Clinical Value of ETCOc in the Diagnosis and Treatment of ABO Hemolytic Disease of the Newborn

TypeobservationalSponsorWomen's Hospital School Of Medicine Zhejiang UniversityRan2023 to 2026Enrolled112ConditionsABO Hemolytic Disease of Newborn
3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.Journal of perinatology : official journal of the California Perinatal Association · 2016
    Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. End-tidal carbon monoxide concentrations measured within 48 hours of birth predict hemolytic hyperbilirubinemia.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Article
  10. Is it time for a precision health approach to the management of newborn hyperbilirubinemia?Journal of perinatology : official journal of the California Perinatal Association · 2024
    Review
  11. A "Gold Standard" Test for Diagnosing and Quantifying Hemolysis in Neonates and Infants.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Review
  12. Reference intervals for end-tidal carbon monoxide of preterm neonates.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  13. Breath Biomarkers in Diagnostic Applications.Molecules (Basel, Switzerland) · 2021
    Review
  14. Article
  15. Article
  16. A new method to evaluate macaque health using exhaled breath: A case study ofJournal of applied physiology (Bethesda, Md. : 1985) · 2017
    Article
  17. Article
  18. Bilirubin production and hour-specific bilirubin levels.Journal of perinatology : official journal of the California Perinatal Association · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

G F TidmarshDivision of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
R J WongDivision of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
D K StevensonDivision of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemolytic disease in newborns can result from a number of conditions, which can place such infants at an increased risk for the development of severe hyperbilirubinemia. Because the catabolism of heme produces equimolar amounts of carbon monoxide (CO) and bilirubin, measurements of end-tidal breath CO (corrected for ambient CO) or ETCOc can serve as an index of hemolysis as well as of bilirubin production from any cause. Elevated levels of ETCOc have been correlated with blood carboxyhemoglobin levels and thus hemolysis. However, the detection of hemolysis can be a clinically challenging problem in newborns. Here, we describe the importance of determining ETCOc levels and their application in identifying infants at risk for developing hyperbilirubinemia associated with hemolysis and other causes of increased bilirubin production.

Indexed as

Breath TestsCarbon MonoxideHemolysisHumansHyperbilirubinemia, NeonatalInfant, NewbornTidal VolumeCarbon Monoxide

Identifiers

PMID24743136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.